You are here

Article info

Article menu
Download PDFPDF
PostScript
Letter
Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies

Authors

  • Guillaume Fargeot Department of Neurology, French National Reference Center for Rare Neuropathies, Bicêtre Hospital, AP-HP, Le Kremlin-Bicetre, France PubMed articlesGoogle scholar articles
  • Corinne Dupel-Pottier Department of Neurology, Rene Dubos Hospital, Pontoise, Île-de-France, France PubMed articlesGoogle scholar articles
  • Maeva Stephant Department of Neurology, French National Reference Center for Rare Neuropathies, Bicêtre Hospital, AP-HP, Le Kremlin-Bicetre, France PubMed articlesGoogle scholar articles
  • Julien Lazarovici Department of Hematology, Gustave Roussy Institute, Villejuif, France PubMed articlesGoogle scholar articles
  • Laure Thomas Regional Pharmacovigilance Center, Henri Mondor Hospital, Créteil, France PubMed articlesGoogle scholar articles
  • Capucine Mouthon-Reignier Department of Neurology, Centre Hospitalier Sud Francilien Site Gilles de Corbeil, Corbeil-Essonnes, France PubMed articlesGoogle scholar articles
  • Benramdane Riad Department of Hematology, Rene Dubos Hospital, Pontoise, Île-de-France, France PubMed articlesGoogle scholar articles
  • Patrice Carde Department of Hematology, Gustave Roussy institute, Paris-Saclay University, Villejuif, France PubMed articlesGoogle scholar articles
  • Giulia Berzero AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Neurologie 2-Mazarin et Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle Epinière (CRICM), UMRS 975, Paris 75013, France; Inserm U 975, CNRS, UMR 7225, Paris, France PubMed articlesGoogle scholar articles
  • Camille Tafani Department of Neurology, Military Training Hospital Percy, Service de Santé des Armées, Paris, France, Military Health Service Academy of Val-de-Grâce, Service de Santé des Armées, Paris, France PubMed articlesGoogle scholar articles
  • Weiss Nicolas Département de Neurologie, Unité de Médecine Intensive Réanimation neurologique, Sorbonne Université, Brain Liver Pitié-Salpêtrière (BLIPS) Study Group, INSERM UMR_S 938, Centre de recherche Saint-Antoine, Maladies métaboliques, biliaires et fibro-inflammatoire du foie, Institute of Cardiometabolism and Nutrition (ICAN), AP-HP. Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France PubMed articlesGoogle scholar articles
  • Karine Viala Department of Clinical Neurophysiology, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix. Assistance Publique Hôpitaux de Paris (APHP), Paris, France PubMed articlesGoogle scholar articles
  • Thierry Maisonobe Department of Clinical Neurophysiology, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix. Assistance Publique Hôpitaux de Paris (APHP), Paris, France PubMed articlesGoogle scholar articles
  • Timothée Lenglet Department of Clinical Neurophysiology, Hôpitaux universitaires Pitié-Salpêtrière-Charles Foix. Assistance Publique Hôpitaux de Paris (APHP), Paris, France PubMed articlesGoogle scholar articles
  • Adrien Wang Department of Neurology, Foch Hospital, Suresnes, France PubMed articlesGoogle scholar articles
  • Laurent Magy Department of Neurology, National Reference Center for Rare Peripheral Neuropathies, University Hospital, Limoges, France PubMed articlesGoogle scholar articles
  • Kevin Bihan Regional Pharmacovigilance Center, Department of Pharmacology, Pitié-Salpêtrière Hospital, AP-HP, Paris, France PubMed articlesGoogle scholar articles
  • Nathalie Gaspar Department of Pediatric and Adolescent Oncology, Gustave Roussy institute, Villejuif, France PubMed articlesGoogle scholar articles
  • David Adams Department of Neurology, French National Reference Center for Rare Neuropathies, Bicêtre Hospital, AP-HP, INSERM U1195 & Paris-Saclay University, Le Kremlin-Bicetre, France PubMed articlesGoogle scholar articles
  • Andoni Echaniz-Laguna Department of Neurology, French National Reference Center for Rare Neuropathies, Bicêtre Hospital, AP-HP, INSERM U1195 & Paris-Saclay University, Le Kremlin-Bicetre, France PubMed articlesGoogle scholar articles
  • Cecile Cauquil Department of Neurology, French National Reference Center for Rare Neuropathies, Bicêtre Hospital, AP-HP, Le Kremlin-Bicetre, France PubMed articlesGoogle scholar articles
  • Dimitri Psimaras AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Service de Neurologie 2-Mazarin et Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle Epinière (CRICM), UMRS 975, Paris 75013, France; Inserm U 975, CNRS, UMR 7225, Paris 75013, France, Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Guillaume Fargeot, Department of Neurology, French National Reference Center for Rare Neuropathies, Bicêtre Hospital, AP-HP, Hopital Bicetre Service de Neurologie Adultes, Le Kremlin-Bicetre 94270, Île-de-France, France; guillaume.fargeot{at}aphp.fr
View Full Text

Citation

Fargeot G, Dupel-Pottier C, Stephant M, et al
Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies
Journal of Neurology, Neurosurgery & Psychiatry 2020;91:786-788.

Publication history

  • Received February 29, 2020
  • Revised April 6, 2020
  • Accepted April 8, 2020
  • First published April 23, 2020.
Online issue publication 
August 30, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.